Abbott Laboratories (BCBA:ABT)

Argentina flag Argentina · Delayed Price · Currency is ARS
40,925
-650 (-1.56%)
At close: Jul 4, 2025, 5:00 PM BRT
27.60%
Market Cap 286.67T
Revenue (ttm) 45.44T
Net Income (ttm) 14.43T
Shares Out n/a
EPS (ttm) 8,264.67
PE Ratio 19.86
Forward PE 25.04
Dividend 541.76 (1.32%)
Ex-Dividend Date May 17, 2025
Volume 86
Average Volume 345
Open 42,800
Previous Close 41,575
Day's Range 40,800 - 43,450
52-Week Range 30,325 - 43,925
Beta n/a
RSI 54.46
Earnings Date Jul 17, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1888
Employees 114,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol ABT
Full Company Profile

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD Financial Statements

News

There is no news available yet.